Topamax, the epilepsy and migraine prevention medication manufactured by Johnson & Johnson (J&J), has long been linked to birth defects affecting the heart, lungs and limbs. A new European study recently reported that there also may be is a significant relationship between the drug and brain and genital defects as well. Acta Neurologica Scandinavica Study A new study published in the March 2013 edition of the medical journal Acta Neurologica Scandinavica provides further medical research on the link between Topamax… Read More
Category: <span>Topamax</span>
Johnson & Johnson’s Topamax, an epilepsy and migraine medication made by J&J subsidiary Ortho McNeil Pharmaceuticals, has been linked to a significantly increased risk of birth defects. According to the U.S. Food & Drug Administration (FDA), women who take Topamax – or its generic form topiragen – during pregnancy are 20 times more likely to have children with defects such as cleft lips and cleft palate (oral cleft) deformities. Topamax Injuries The FDA issued a warning letter in 2011 to… Read More
